Warning letter
Schindele Enterprises dba Midwest Wholesale: warning letter of Jul 17, 2014
FDA warning letter 418843 · Kansas City District Office
Key facts
| Reference number | 418843 |
|---|---|
| Company | Schindele Enterprises dba Midwest Wholesale |
| Subject | Unapproved/Misbranded drugs |
| Issue date | Jul 17, 2014 |
| Posted date | Jul 29, 2014 |
| Issuing office | Kansas City District Office |
| Product type | Drugs |
| CFR sections cited | 201.5 |
| Inspection city | Nixa |
| Inspection ZIP | 65714 |
| Inspection start date | Oct 21, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: